MSHS Translational Science Hub

联系PD/PI：Sampson，Hugh 成立于2009年，导管，临床和转化科学研究所在伊坎学院， 西奈山医学（ISMMS）包括一个多元化的研究参与的利益相关者和研究网络 参与者2013年9月，我们成立了一个新的、综合的、扩大的卫生系统，称为“山”。 西奈卫生系统（MSHS），其中包括ISMMS和7个成员医院校园，大大扩大 使我们的服务区域多样化，让我们有机会接触到更加多样化的教职员工，学员， 研究参与者和随行利益相关者。2012年，ISMMS和伦斯勒理工学院 研究所（RPI）达成了旨在促进教育和研究的长期合作伙伴关系 合作，利用MSHS在生物医学研究和患者护理方面的卓越表现，以及RPI的优势 在工程和计算科学中。Conduits的使命是通过改变 这个中心变成了一个转化研究实验室，与我们多样化的患者群体合作， 利益相关者、机构临床医生和科学家以及其他CTSA网络中心的研究人员，以确保 高质量的研究，研究教育，以及独特的创新资源的开发，以促进 生物医学发现在“生命周期”中的转化。我们将通过实现以下目标来实现这一目标 具体目标：1：确保翻译研究人员拥有必要的技能和知识， 通过为高质量的临床和转化研究开发创新课程， 培训各级学生、调查人员和研究人员。2：扩大方案，进一步促进 通过招聘、教育、指导和留住最有才华的学生来实现劳动力多元化， 教师和研究人员，3：在我们的内部培养一个协作，合议，跨学科（共享）的环境 CTSA中心和CTSA网络，包括激励形成多学科翻译 团队我们还将与其他CTSA中心合作，以改善转化研究。4：协调 通过集成安全电子健康记录， （EHR）、基于网络的临床试验管理系统和机构数据库，以更好地吸引患者 和社区临床医生参与临床试验和社区参与研究。5：吸引不同群体的参与 在转化研究的所有阶段，地方和国家层面的利益相关者，包括患者， 护理人员、临床医生和医疗保健提供代表、倡导团体、NIH研究所和中心， 其他NCATS资助CTSA中心，生物技术和制药公司和风险投资公司。第六章： 在整个生命周期中纳入转化研究，特别关注儿科研究，老年医学研究， 人口和受健康差距影响的特殊人口。7：持续创新精简 研究行政监督和程序，以尽量减少障碍，查明和纠正差距，确保 质量和保证，监测成果并收集利益攸关方的反馈。 项目摘要/摘要第222页 联系PD/PI：Sampson，Hugh （

Contact PD/PI: Sampson, Hugh Established in 2009, Conduits, the Institute for Clinical and Translational Sciences at the Icahn School of Medicine at Mount Sinai (ISMMS) includes a diverse network of research-involved stakeholders and research participants. In September 2013, we formed a new, integrated and expanded health system called the Mount Sinai Health System (MSHS), which includes the ISMMS and 7 member hospital campuses, vastly enlarging and diversifying our catchment area and giving us access to an even more diverse faculty and staff, trainees, research participants and accompanying stakeholders. In 2012, ISMMS and RensseIaer Polytechnic Institute (RPI) entered into a long-term partnership designed to foster educational and research collaborations, which exploits MSHS excellence in biomedical research and patient care, and RPI's strengths in engineering and computational sciences. Conduits mission is to advance human health by transforming this hub into a translational research laboratory, partnering with our diverse patient population, other stakeholders, institutional clinicians and scientists, and investigators at other CTSA Network Hubs to ensure high quality research, research education, and development of unique, innovative resources to catalyze translation of biomedical discoveries across the “lifespan.” We will accomplish this by achieving the following Specific Aims: 1: Ensure that translational researchers have the skills and knowledge necessary to advance translation of discoveries by developing innovative curricula for high quality clinical and translational research training of students, investigators and research staff at all levels. 2: Expand programs to further promote workforce diversity through recruitment, education, mentoring and retention of the most talented students, faculty and researchers, 3: Foster a collaborative, collegial, transdisciplinary (shared) environment within our CTSA hub and the CTSA Network that includes incentives for formation of multi-disciplinary translational teams. We will also collaborate with other CTSA hubs to improve translational research. 4: Coordinate the health care delivery and translational research enterprise by integrating secure electronic health records (EHRs), web-based clinical trials management systems and institutional databanks to better engage patients and community clinicians in clinical trials and community engaged research. 5: Engage a diverse group of stakeholders at the local and national level in all phases of translational research, including patients, caregivers, clinicians, and healthcare delivery representatives, advocacy groups, NIH Institutes & Centers, other NCATS funded CTSA Hubs, biotech and pharmaceutical companies and venture capital firms. 6: Incorporate translational research across the lifespan, with particular focus on pediatric research, geriatric populations, and special populations affected by health disparities. 7: Continue to innovate and streamline research administrative oversight and processes to minimize roadblocks, identify and rectify gaps, ensure quality and assurance, monitor outcomes and garner feedback from stakeholders. Project Summary/Abstract Page 222 Contact PD/PI: Sampson, Hugh Narrative (